PATENT CLAIM ANALYSIS

Application Number: 15760387
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "211040"]

Abstract:
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Claim (Index 13):
The compound of  claim 11 , wherein the compound is represented by: wherein R 21  is selected, for each occurrence, from the group consisting of H, halogen, and CH 3 .

Metadata:
- Claim Count in Document: 10.0
- Percentile: 90.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15760343', '15125911', '15030378', '15566633', '15539392']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8278857635466258
- 35 USC 102 Novelty (BERT): 0.5486735969028723
- Combined Prediction Score: 0.7999645468822505
- Mean Citation Score: 359.835372
- Max Citation Score: 410.44235
- Similarity Product: 301.87427228307126

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test